Although there are no biochemical markers specific for MBD of prematurity, the bone metabolism can be assessed by dosing calcium, phosphate, alkaline phosphatase (ALP), parathormone (PTH) and vitamin D in the first weeks of life, especially in high-risk patients such as VLBW infants. Here, PTH is linked to Marchiafava-Bignami disease.